Search

Your search keyword '"James A. Feinstein"' showing total 78 results

Search Constraints

Start Over You searched for: Author "James A. Feinstein" Remove constraint Author: "James A. Feinstein"
78 results on '"James A. Feinstein"'

Search Results

1. Ontologizing health systems data at scale: making translational discovery a reality

2. A coordinated approach for managing polypharmacy among children with medical complexity: rationale and design of the Pediatric Medication Therapy Management (pMTM) randomized controlled trial

Catalog

Books, media, physical & digital resources

3. Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa

4. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa

5. Emerging Methodologies in Pediatric Palliative Care Research: Six Case Studies

7. Ontologizing Health Systems Data at Scale: Making Translational Discovery a Reality.

9. Anticholinergic Medications and Parent-Reported Anticholinergic Symptoms in Neurologically Impaired Children

10. Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery.

11. Validation of Neurologic Impairment Diagnosis Codes as Signifying Documented Functional Impairment in Hospitalized Children

12. Characteristics Associated With Serious Self-Harm Events in Children and Adolescents

13. Identifying Acute Neuropsychiatric Events in Children and Adolescents

14. Clinical characteristics of children with severe neurologic impairment: A scoping review

15. Guideline-Concordant Antiviral Treatment in Children at High Risk for Influenza Complications

16. Readmissions Following Hospitalization for Infection in Children With or Without Medical Complexity

17. Identifying opportunities for pediatric medication therapy management in children with medical complexity

18. Trends in Health Care Use and Spending for Young Children With Neurologic Impairment

19. Medications Reconciled at Discharge Versus Admission Among Inpatients at a Children’s Hospital

20. Complexity of Medication Regimens for Children With Neurological Impairment

22. Outcome measures in pediatric polypharmacy research: a scoping review

23. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database

24. Parent-Reported Symptoms and Medications Used Among Children With Severe Neurological Impairment

25. Prevalence of Clinically Significant Drug-Drug Interactions Across US Children’s Hospitals

26. Timing of Co-occurring Chronic Conditions in Children With Neurologic Impairment

27. Identifying Important Clinical Symptoms in Children With Severe Neurological Impairment Using Parent-Reported Outcomes of Symptoms

28. Perceived Versus Demonstrated Understanding of the Complex Medications of Medically Complex Children

29. Approach and Safety of Esophageal Dilation for Treatment of Strictures in Children With Epidermolysis Bullosa

30. Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)

31. A Scoping Review of Medications Studied in Pediatric Polypharmacy Research

32. Identification of Children With High-Intensity Neurological Impairment

33. Management of Self-Injurious Behaviors in Children with Neurodevelopmental Disorders—A Pharmacotherapy Overview

34. Outpatient Prescription Opioid Use in Pediatric Medicaid Enrollees With Special Health Care Needs

35. Data Science for Child Health

36. Chronic Medication Use in Children Insured by Medicaid: A Multistate Retrospective Cohort Study

37. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America

38. Choosing medications wisely: Is it time to address paediatric polypharmacy?

39. Variation of the prevalence of pediatric polypharmacy: A scoping review

40. Defining pediatric polypharmacy: A scoping review

41. The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patients

42. Potential Drug−Drug Interactions in Infant, Child, and Adolescent Patients in Children’s Hospitals

43. Medicaid Managed Care Structures and Care Coordination

44. Steps Toward Evidence-Based Management of Sleep Problems in Children with Neurodevelopmental Disorders

45. Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals

46. Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review

47. Pediatric Nurses' Individual and Group Assessments of Palliative, End-of-Life, and Bereavement Care

48. R Package for Pediatric Complex Chronic Condition Classification

50. Emerging Methodologies in Pediatric Palliative Care Research: Six Case Studies